Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Other Operating Expenses: 2020-2024

Historic Other Operating Expenses for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$31.0 million.

  • Burning Rock Biotech's Other Operating Expenses rose 19.35% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.4 million, marking a year-over-year increase of 81.91%. This contributed to the annual value of -$31.0 million for FY2024, which is 80.43% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's Other Operating Expenses is -$31.0 million, which was up 80.43% from -$158.2 million recorded in FY2023.
  • Burning Rock Biotech's Other Operating Expenses' 5-year high stood at -$31.0 million during FY2024, with a 5-year trough of -$218.5 million in FY2022.
  • Its 3-year average for Other Operating Expenses is -$135.9 million, with a median of -$158.2 million in 2023.
  • As far as peak fluctuations go, Burning Rock Biotech's Other Operating Expenses tumbled by 73.81% in 2021, and later skyrocketed by 80.43% in 2024.
  • Burning Rock Biotech's Other Operating Expenses (MRY) stood at -$115.9 million in 2020, then crashed by 73.81% to -$201.4 million in 2021, then dropped by 8.46% to -$218.5 million in 2022, then increased by 27.58% to -$158.2 million in 2023, then skyrocketed by 80.43% to -$31.0 million in 2024.
  • Its Other Operating Expenses was -$31.0 million in FY2024, compared to -$158.2 million in FY2023 and -$218.5 million in FY2022.